Ed Arce
Stock Analyst at Westpark Capital
(4.86)
# 357
Out of 4,429 analysts
1074
Total ratings
48.8%
Success rate
22.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ed Arce
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TLPH Talphera | Initiated Coverage: Buy | $6 → $3 | $0.9822 | +205.44% | 88 | Apr 30, 2026 | |
| MTVA MetaVia | Maintained: Buy | $132 | $1.57 | +8,307.64% | 9 | Sep 17, 2025 | |
| ARCT Arcturus Therapeutics Holdings | Maintained: Buy | $60 | $7.23 | n/a | 72 | Apr 11, 2025 | |
| UNCY Unicycive Therapeutics | Maintained: Buy | $75 | $7.87 | n/a | 33 | Apr 11, 2025 | |
| AKBA Akebia Therapeutics | Maintained: Buy | $7.5 | $1.09 | n/a | 85 | Apr 4, 2025 | |
| IVA Inventiva | Reiterated: Buy | $13 | $3.51 | n/a | 32 | Apr 3, 2025 | |
| GALT Galectin Therapeutics | Maintained: Hold | n/a | $2.80 | n/a | 56 | Apr 2, 2025 | |
| ALGS Aligos Therapeutics | Maintained: Buy | $70 | $5.69 | n/a | 6 | Mar 31, 2025 | |
| ASMB Assembly Biosciences | Maintained: Hold | n/a | $25.06 | n/a | 30 | Mar 21, 2025 | |
| ACXP Acurx Pharmaceuticals | Reiterated: Buy | $240 | $1.51 | n/a | 21 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.16 | n/a | 36 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 | $7.10 | n/a | 10 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $400 → $405 | $512.88 | n/a | 42 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $66 → $72 | $107.77 | n/a | 60 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5.5 | $6.37 | n/a | 13 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $95 | $29.03 | n/a | 10 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $13.34 | n/a | 16 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $4.52 | n/a | 37 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $22 | $55.11 | n/a | 26 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 | $30.83 | n/a | 2 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $0.0416 | n/a | 44 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $17.53 | n/a | 90 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.71 | n/a | 12 | Apr 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 | $0.165 | n/a | 7 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $38.43 | n/a | 12 | Jan 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.5641 | n/a | 39 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 51 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $14.28 | n/a | 13 | Dec 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.30 | n/a | 33 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $10.72 | n/a | 3 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €12.00 | $3.01 | n/a | 15 | Mar 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 → $31 | $33.45 | n/a | 11 | Feb 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.13 | n/a | 5 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 | $2.21 | n/a | 5 | Aug 12, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.25 | $0.011 | n/a | 14 | Mar 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 | $32.37 | n/a | 2 | Nov 28, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.535 | n/a | 8 | Nov 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.0001 | n/a | 1 | Jan 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $9.14 | n/a | 12 | Jan 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7.5 → $5 | $0.0004 | n/a | 8 | Jan 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $42.00 | n/a | 3 | Nov 14, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $0.5 | $0.0013 | n/a | 2 | Mar 19, 2013 |
Talphera
Apr 30, 2026
Initiated Coverage: Buy
Price Target: $6 → $3
Current: $0.9822
Upside: +205.44%
MetaVia
Sep 17, 2025
Maintained: Buy
Price Target: $132
Current: $1.57
Upside: +8,307.64%
Arcturus Therapeutics Holdings
Apr 11, 2025
Maintained: Buy
Price Target: $60
Current: $7.23
Upside: n/a
Unicycive Therapeutics
Apr 11, 2025
Maintained: Buy
Price Target: $75
Current: $7.87
Upside: n/a
Akebia Therapeutics
Apr 4, 2025
Maintained: Buy
Price Target: $7.5
Current: $1.09
Upside: n/a
Inventiva
Apr 3, 2025
Reiterated: Buy
Price Target: $13
Current: $3.51
Upside: n/a
Galectin Therapeutics
Apr 2, 2025
Maintained: Hold
Price Target: n/a
Current: $2.80
Upside: n/a
Aligos Therapeutics
Mar 31, 2025
Maintained: Buy
Price Target: $70
Current: $5.69
Upside: n/a
Assembly Biosciences
Mar 21, 2025
Maintained: Hold
Price Target: n/a
Current: $25.06
Upside: n/a
Acurx Pharmaceuticals
Mar 20, 2025
Reiterated: Buy
Price Target: $240
Current: $1.51
Upside: n/a
Mar 18, 2025
Maintained: Hold
Price Target: n/a
Current: $1.16
Upside: n/a
Mar 11, 2025
Maintained: Buy
Price Target: $32
Current: $7.10
Upside: n/a
Feb 27, 2025
Maintained: Buy
Price Target: $400 → $405
Current: $512.88
Upside: n/a
Feb 27, 2025
Maintained: Buy
Price Target: $66 → $72
Current: $107.77
Upside: n/a
Feb 20, 2025
Maintained: Hold
Price Target: $5.5
Current: $6.37
Upside: n/a
Feb 18, 2025
Maintained: Buy
Price Target: $95
Current: $29.03
Upside: n/a
Feb 10, 2025
Maintained: Buy
Price Target: $18
Current: $13.34
Upside: n/a
Jan 21, 2025
Maintained: Buy
Price Target: $5
Current: $4.52
Upside: n/a
Jan 14, 2025
Maintained: Buy
Price Target: $18 → $22
Current: $55.11
Upside: n/a
Jan 14, 2025
Maintained: Buy
Price Target: $48
Current: $30.83
Upside: n/a
Sep 10, 2024
Maintained: Buy
Price Target: $5
Current: $0.0416
Upside: n/a
Sep 5, 2024
Maintained: Buy
Price Target: $13
Current: $17.53
Upside: n/a
Apr 24, 2024
Rated: Hold
Price Target: n/a
Current: $0.71
Upside: n/a
Mar 26, 2024
Maintained: Buy
Price Target: $120
Current: $0.165
Upside: n/a
Jan 25, 2024
Maintained: Buy
Price Target: $25
Current: $38.43
Upside: n/a
Mar 27, 2023
Rated: Hold
Price Target: n/a
Current: $0.5641
Upside: n/a
Mar 27, 2023
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Dec 21, 2021
Maintained: Hold
Price Target: n/a
Current: $14.28
Upside: n/a
Nov 29, 2021
Maintained: Hold
Price Target: n/a
Current: $0.30
Upside: n/a
May 12, 2020
Downgraded: Hold
Price Target: n/a
Current: $10.72
Upside: n/a
Mar 18, 2020
Maintained: Buy
Price Target: €12.00
Current: $3.01
Upside: n/a
Feb 7, 2020
Maintained: Buy
Price Target: $29 → $31
Current: $33.45
Upside: n/a
Nov 11, 2019
Maintained: Hold
Price Target: n/a
Current: $1.13
Upside: n/a
Aug 12, 2019
Maintained: Buy
Price Target: $27
Current: $2.21
Upside: n/a
Mar 14, 2019
Maintained: Hold
Price Target: $1.25
Current: $0.011
Upside: n/a
Nov 28, 2017
Rated: Buy
Price Target: $7
Current: $32.37
Upside: n/a
Nov 6, 2017
Maintained: Hold
Price Target: n/a
Current: $0.535
Upside: n/a
Jan 30, 2015
Reiterated: Buy
Price Target: $5
Current: $0.0001
Upside: n/a
Jan 26, 2015
Maintained: Buy
Price Target: $20
Current: $9.14
Upside: n/a
Jan 9, 2015
Reiterated: Buy
Price Target: $7.5 → $5
Current: $0.0004
Upside: n/a
Nov 14, 2014
Reiterated: Buy
Price Target: $9
Current: $42.00
Upside: n/a
Mar 19, 2013
Downgraded: Sell
Price Target: $0.5
Current: $0.0013
Upside: n/a